Compound details
28-Norbrassinolide
| Compound ID | CDAMM01081 |
|---|---|
| Common name | 28-Norbrassinolide | IUPAC name | 15-(3,4-dihydroxy-6-methylheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.02,7.012,16]octadecan-8-one |
| Molecular formula | C27H46O6 |
| Retention time | 0.43 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 467.33 | Theoretical mz | 467.336 |
| Error | 13.22 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.2985 |
| Inchi key | CJNLSQRTIXIHGW-BLCYKFRANA-N |
|---|---|
| Smiles | O=C1OCC2C3CCC(C(C)C(O)C(O)CC(C)C)C3(C)CCC2C4(C)CC(O)C(O)CC14 |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P00797 | REN | Renin | T61622 | SwissTargetPrediction |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SEA |
| P08473 | MME | Neprilysin | T05409 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P31213 | SRD5A2 | Steroid 5-alpha-reductase 2 | T71390 | SEA |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O75469 | NR1I2 | Pregnane X receptor | T82702 | SwissTargetPrediction |
| P18405 | SRD5A1 | Steroid 5-alpha-reductase 1 | T70309 | SEA |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| Q9UHC9 | NPC1L1 | Niemann-Pick C1-like protein 1 | T33901 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction and SEA |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P11473 | VDR | Vitamin D receptor | T34234 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P16662 | UGT2B7 | UDP-glucuronosyltransferase 2B7 | T62815 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SEA |
| Q9UM73 | ALK | ALK tyrosine kinase receptor | T56418 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SwissTargetPrediction |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P53667 | LIMK1 | LIM domain kinase 1 | T70840 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P04035 | HMGCR | HMG-CoA reductase | T53585 | SwissTargetPrediction |
| P05093 | CYP17A1 | Cytochrome P450 17A1 | T89041 | SEA |
| P20701 | ITGAL | Intercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2 | T35640 | SwissTargetPrediction |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | T09538 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P49759 | CLK1 | Dual specificty protein kinase CLK1 | T46685 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| Q9BPW0 | PPP5C | Serine/threonine-protein phosphatase | T04123 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SwissTargetPrediction |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SwissTargetPrediction |
| P06737 | PYGL | Liver glycogen phosphorylase | T19184 | SwissTargetPrediction |
| P08922 | ROS1 | Proto-oncogene tyrosine-protein kinase ROS | T69128 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| Q99835 | SMO | Smoothened homolog | T66505 | SwissTargetPrediction |
| P49336 | CDK8 | Cell division protein kinase 8 | T10822 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P35398 | RORA | Nuclear receptor ROR-alpha | T43206 | SEA |
| P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | T40111 | SwissTargetPrediction |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| Q16602 | CALCRL | Calcitonin gene-related peptide type 1 receptor | T02226 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| P37023 | ACVRL1 | Serine/threonine-protein kinase receptor R3 | T36959 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | T37961 | SwissTargetPrediction |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| Q92630 | DYRK2 | Dual-specificity tyrosine-phosphorylation regulated kinase 2 | T39486 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| P29401 | TKT | Transketolase | T67754 | SwissTargetPrediction |
| Q12866 | MERTK | Proto-oncogene tyrosine-protein kinase MER | T55781 | SwissTargetPrediction |
| Q00796 | SORD | Sorbitol dehydrogenase | T59445 | SwissTargetPrediction |
| Q06418 | TYRO3 | Tyrosine-protein kinase receptor TYRO3 | T94880 | SwissTargetPrediction |
| P11137 | MAP2 | Microtubule-associated protein 2 | T23276 | SwissTargetPrediction |
| Q5VT25 | CDC42BPA | Serine or threonine-protein kinase MRCK-A | T00075 | SwissTargetPrediction |
| Q9HBA0 | TRPV4 | Transient receptor potential cation channel subfamily V member 4 | T64213 | SwissTargetPrediction |
| O95136 | S1PR2 | Sphingosine 1-phosphate receptor Edg-5 | T47888 | SwissTargetPrediction |
| Q14973 | SLC10A1 | Bile acid transporter | T99189 | SEA |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| O15439 | ABCC4 | Multidrug resistance protein 4 | T39919 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T61622 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P00797 | REN |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T05409 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08473 | MME |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T71390 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P31213 | SRD5A2 |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T70309 | DI0347 | Prostate disease | [ICD-11: GA91] | P18405 | SRD5A1 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T33901 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q9UHC9 | NPC1L1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T34234 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P11473 | VDR |
| T34234 | DI0171 | Hair/hair growth developmental defect | [ICD-11: LC30] | P11473 | VDR |
| T34234 | DI0189 | Hyper-parathyroidism | [ICD-11: 5A51] | P11473 | VDR |
| T34234 | DI0195 | Hypo-parathyroidism | [ICD-11: 5A50] | P11473 | VDR |
| T34234 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P11473 | VDR |
| T34234 | DI0351 | Psoriasis | [ICD-11: EA90] | P11473 | VDR |
| T34234 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | P11473 | VDR |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T56418 | DI0238 | Lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T56418 | DI0251 | Mature T-cell lymphoma | [ICD-11: 2A90] | Q9UM73 | ALK |
| T56418 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q9UM73 | ALK |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T53585 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P04035 | HMGCR |
| T53585 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P04035 | HMGCR |
| T53585 | DI0128 | Dyslipidemia | [ICD-11: 5C80-5C81] | P04035 | HMGCR |
| T53585 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P04035 | HMGCR |
| T53585 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04035 | HMGCR |
| T53585 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P04035 | HMGCR |
| T53585 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P04035 | HMGCR |
| T89041 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P05093 | CYP17A1 |
| T35640 | DI0351 | Psoriasis | [ICD-11: EA90] | P20701 | ITGAL |
| T35640 | DI0436 | Visual system disease | [ICD-11: 9E1Z] | P20701 | ITGAL |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T09538 | DI0164 | Genetic prion disease | [ICD-11: 8E02] | P05186 | ALPL |
| T09538 | DI0330 | Parasitic infection | [ICD-11: 1D0Y-1G2Z] | P05186 | ALPL |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T69128 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08922 | ROS1 |
| T69128 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08922 | ROS1 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T66505 | DI0047 | Basal cell carcinoma | [ICD-11: 2C32] | Q99835 | SMO |
| T66505 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | Q99835 | SMO |
| T66505 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99835 | SMO |
| T10822 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P49336 | CDK8 |
| T10822 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P49336 | CDK8 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T43206 | DI0235 | Liver cancer | [ICD-11: 2C12] | P35398 | RORA |
| T43206 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35398 | RORA |
| T40111 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P20839 | IMPDH1 |
| T40111 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P20839 | IMPDH1 |
| T40111 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P20839 | IMPDH1 |
| T40111 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P20839 | IMPDH1 |
| T40111 | DI0413 | Transplant rejection | [ICD-11: NE84] | P20839 | IMPDH1 |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T36959 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P37023 | ACVRL1 |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T55781 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q12866 | MERTK |
| T55781 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q12866 | MERTK |
| T55781 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q12866 | MERTK |
| T55781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q12866 | MERTK |
| T94880 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06418 | TYRO3 |
| T23276 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P11137 | MAP2 |
| T23276 | DI0252 | Melanoma | [ICD-11: 2C30] | P11137 | MAP2 |
| T23276 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P11137 | MAP2 |
| T23276 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11137 | MAP2 |
| T64213 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9HBA0 | TRPV4 |
| T64213 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q9HBA0 | TRPV4 |
| T64213 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | Q9HBA0 | TRPV4 |
| T47888 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | O95136 | S1PR2 |
| T99189 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q14973 | SLC10A1 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |